655 related articles for article (PubMed ID: 31456182)
1. Bone Metastasis of Breast Cancer.
Tahara RK; Brewer TM; Theriault RL; Ueno NT
Adv Exp Med Biol; 2019; 1152():105-129. PubMed ID: 31456182
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
Futakuchi M; Fukamachi K; Suzui M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
[TBL] [Abstract][Full Text] [Related]
3. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer bone metastases: pathogenesis and therapeutic targets.
Brook N; Brook E; Dharmarajan A; Dass CR; Chan A
Int J Biochem Cell Biol; 2018 Mar; 96():63-78. PubMed ID: 29309917
[TBL] [Abstract][Full Text] [Related]
5. [Management of bone metastases from breast cancer].
Hayashi N; Yamauchi H; Nakamura S
Gan To Kagaku Ryoho; 2012 Aug; 39(8):1174-7. PubMed ID: 22902439
[TBL] [Abstract][Full Text] [Related]
6. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
Lefley D; Howard F; Arshad F; Bradbury S; Brown H; Tulotta C; Eyre R; Alférez D; Wilkinson JM; Holen I; Clarke RB; Ottewell P
Breast Cancer Res; 2019 Nov; 21(1):130. PubMed ID: 31783893
[TBL] [Abstract][Full Text] [Related]
7. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
[TBL] [Abstract][Full Text] [Related]
8. Bone metastasis in breast cancer.
Theriault RL; Hortobagyi GN
Anticancer Drugs; 1992 Oct; 3(5):455-62. PubMed ID: 1450438
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials in metastatic breast cancer to bone: past--present--future.
Body JJ
Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
[TBL] [Abstract][Full Text] [Related]
11. Targeting of therapeutic agents to bone to treat metastatic cancer.
Bagi CM
Adv Drug Deliv Rev; 2005 May; 57(7):995-1010. PubMed ID: 15876400
[TBL] [Abstract][Full Text] [Related]
12. Metastatic bone disease from breast cancer: a review of minimally invasive techniques for diagnosis and treatment.
Filippiadis D; Mavrogenis AF; Mazioti A; Palialexis K; Megaloikonomos PD; Papagelopoulos PJ; Kelekis A
Eur J Orthop Surg Traumatol; 2017 Aug; 27(6):729-736. PubMed ID: 28597402
[TBL] [Abstract][Full Text] [Related]
13. Understanding and optimizing bone health in breast cancer.
Guise TA; Brufsky A; Coleman RE
Curr Med Res Opin; 2010 Dec; 26 Suppl 3():3-20. PubMed ID: 21050131
[TBL] [Abstract][Full Text] [Related]
14. Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK Intergroup.
Rordorf T; Hassan AA; Azim H; Alexandru E; Er O; Gokmen E; Güral Z; Mardiak J; Minchev V; Peintinger F; Szendroi M; Takac I; Tesarova P; Vorobiof D; Vrbanec D; Yildiz R; Yücel S; Zekri J; Oyan B; ;
Breast; 2014 Oct; 23(5):511-25. PubMed ID: 24986766
[TBL] [Abstract][Full Text] [Related]
15. Skeletal-related events among breast and prostate cancer patients: towards new treatment initiation in Malaysia's hospital setting.
Ezat SW; Syed Junid SM; Noraziani K; Zafar A; Saperi S; Nur AM; Aizuddin AN; Ismail F; Abdullah N; Zainuddin ZM; Mohd Kassim AY; Haflah NH
Asian Pac J Cancer Prev; 2013; 14(5):3357-62. PubMed ID: 23803129
[TBL] [Abstract][Full Text] [Related]
16. Painful boney metastases.
Smith HS; Barkin RL
Am J Ther; 2014; 21(2):106-30. PubMed ID: 23344095
[TBL] [Abstract][Full Text] [Related]
17. [Anti-RANKL antibody for the management of bone metastasis].
Yoneda T
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1439-45. PubMed ID: 21918338
[TBL] [Abstract][Full Text] [Related]
18. [Encounter of cancer cells with bone. Treatment of bone metastases from breast cancer].
Taguchi T
Clin Calcium; 2011 Mar; 21(3):429-38. PubMed ID: 21358065
[TBL] [Abstract][Full Text] [Related]
19. Incidence and prognostic factors of Japanese breast cancer patients with bone metastasis.
Oka H; Kondoh T; Seichi A; Hozumi T; Nakamura K
J Orthop Sci; 2006 Jan; 11(1):13-9. PubMed ID: 16437343
[TBL] [Abstract][Full Text] [Related]
20. The use of bisphosphonates in patients with breast cancer.
Van Poznak CH
Cancer Control; 2002; 9(6):480-9. PubMed ID: 12514566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
